Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| BNAI | Brand Engagement Network | $6.51 | $2.90 | 80.41% | 19.4M | $16M | $1.18$10.50 |
| AZI | Autozi Internet Technology (Global) | $3.74 | $0.72 | 23.84% | 21.3M | $309M | $1.33$69.00 |
| LFS | Leifras | $2.98 | $0.51 | 20.53% | 45.6K | $65M | $1.58$12.49 |
| BEEM | Beam Global | $2.12 | $0.35 | 19.77% | 42.4M | $34M | $1.33$4.04 |
| AHMA | Ambitions Enterprise Management L.l.c | $14.56 | $2.22 | 17.99% | 1.3M | $364M | $4.00$18.20 |
| BMNG | Themes ETF Trust - Leverage Shares 2x Long Bmnr Daily ETF | $4.61 | $0.59 | 14.68% | 4.4M | - | $3.04$17.35 |
| ORIC | ORIC Pharmaceuticals | $11.61 | $1.47 | 14.50% | 33.2K | $988M | $3.90$14.93 |
| MSTX | Tidal Trust II - Defiance Daily Target 2x Long Mstr ETF | $5.55 | $0.70 | 14.43% | 24.7M | - | $3.73$64.40 |
| MSTP | GraniteShares ETF Trust - GraniteShares 2x Long Mstr Daily ETF | $3.98 | $0.50 | 14.37% | 440.3K | - | $2.69$32.23 |
| IQST | iQSTEL | $3.04 | $0.38 | 14.29% | 127.5K | $12M | $2.63$22.95 |
Related Articles
Featured Article
1 Brand-New Big Reason to Buy This Biotech Stock Right Now
Alex Carchidi|Oct 24, 2024
This stock currently has a good balance of risk and potential rewards.
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
Alex Carchidi|Oct 3, 2024
These two could become direct competitors relatively soon.
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Alex Carchidi|Sep 19, 2023
The gene-editing market is moving fast, and it pays to get to know some of these companies.
Advertisement
Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?
Alex Carchidi|Jul 9, 2023
Its new focus on profitability might complicate its chances of growth.
2 Meme Stocks That Are Down More Than 80% From Their 52-Week Highs
David Jagielski, CPA|Apr 27, 2022
Are these stocks too cheap to pass up right now?
Clover Health Blows Past Expectations. Time to Buy?
Cory Renauer|Feb 24, 2022
An earnings beat and an improved outlook make this digital healthcare stock hard to ignore.
3 Reasons Clover Health Is a Growth Stock That Could Make You Richer Over the Long Term
Jason Hawthorne|Sep 15, 2021
If you listen, you can hear the progress amid the noise.
Why Clover Health Might Not Bring You Good Luck
David Moadel|Sep 14, 2021
The innovative health insurer presents an intriguing -- but flawed -- risk-to-reward profile.
3 Things About Clover Health That Smart Investors Know
Alex Carchidi|Aug 29, 2021
Complications abound, but they're not all bad.
